Research Analysts’ Recent Ratings Changes for Silicon Laboratories (SLAB)

Several analysts have recently updated their ratings and price targets for Silicon Laboratories (NASDAQ: SLAB):

• 11/8/2024 – Silicon Laboratories was upgraded by analysts at StockNews.com to a “sell” rating.
• 11/5/2024 – Silicon Laboratories had its price target lowered by analysts at JPMorgan Chase & Co. from $150.00 to $135.00. They now have an “overweight” rating on the stock.
• 11/5/2024 – Silicon Laboratories had its price target lowered by analysts at KeyCorp from $150.00 to $115.00. They now have an “overweight” rating on the stock.
• 11/5/2024 – Silicon Laboratories had its “hold” rating reaffirmed by analysts at Benchmark Co..
• 11/5/2024 – Silicon Laboratories had its price target lowered by analysts at Morgan Stanley from $123.00 to $97.00. They now have an “equal weight” rating on the stock.
• 11/5/2024 – Silicon Laboratories had its price target lowered by analysts at Barclays PLC from $120.00 to $75.00. They now have an “equal weight” rating on the stock.
• 11/5/2024 – Silicon Laboratories had its price target lowered by analysts at Stifel Nicolaus from $160.00 to $135.00. They now have a “buy” rating on the stock.
• 10/30/2024 – Silicon Laboratories was upgraded by analysts at StockNews.com to a “sell” rating.

Silicon Laboratories Trading Down 2.7 %

Shares of SLAB stock traded down $2.97 during trading hours on Tuesday, reaching $105.41. 57,771 shares of the company’s stock were exchanged, compared to its average volume of 298,009. The stock has a market cap of $3.42 billion, a PE ratio of -14.24 and a beta of 1.20. The stock’s fifty day moving average price is $111.89 and its two-hundred day moving average price is $115.29. Silicon Laboratories Inc. has a 1 year low of $93.30 and a 1 year high of $154.91.

Silicon Laboratories (NASDAQ:SLAB) last released its quarterly earnings results on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.07. Silicon Laboratories had a negative net margin of 46.93% and a negative return on equity of 12.60%. The business had revenue of $166.00 million for the quarter, compared to the consensus estimate of $165.50 million. During the same period in the previous year, the firm earned $0.48 EPS. The business’s revenue was down 18.5% on a year-over-year basis. On average, equities analysts expect that Silicon Laboratories Inc. will post -3.56 EPS for the current fiscal year.

Insider Buying and Selling

In other news, SVP Brandon Tolany sold 845 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $115.00, for a total transaction of $97,175.00. Following the completion of the transaction, the senior vice president now directly owns 43,615 shares of the company’s stock, valued at approximately $5,015,725. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.72% of the stock is currently owned by company insiders.

Institutional Trading of Silicon Laboratories

Several hedge funds have recently modified their holdings of SLAB. Cullen Frost Bankers Inc. bought a new stake in shares of Silicon Laboratories in the second quarter valued at about $28,000. Advisors Asset Management Inc. boosted its stake in Silicon Laboratories by 159.4% during the third quarter. Advisors Asset Management Inc. now owns 275 shares of the semiconductor company’s stock worth $32,000 after acquiring an additional 169 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Silicon Laboratories by 84.1% during the third quarter. GAMMA Investing LLC now owns 497 shares of the semiconductor company’s stock valued at $57,000 after acquiring an additional 227 shares in the last quarter. Daiwa Securities Group Inc. bought a new position in Silicon Laboratories in the 2nd quarter valued at about $60,000. Finally, Migdal Insurance & Financial Holdings Ltd. bought a new stake in Silicon Laboratories during the second quarter worth $82,000.

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.